Faculty profile

Robert Siemens

ResearcherBiomedical and Molecular SciencesQueen's University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Queen's University directory, so their courses and email address may be missing. Find their university profile.

Robert Siemens

Researcher

Biomedical and Molecular Sciences

Health Sciences

Queen's University

Kingston, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
6 publications in the last five years, latest in 2026.
Principal investigator on 1 research grant (1 CIHR), most recently in 2020.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

121

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Adaptive Immunity Bladder Cancer Immunotherapy Innate Immunity

Latest papers

Shift happens: a fairness-oriented framework for medical classification under hidden bias.
International journal of computer assisted radiology and surgery · 2026
Open access publishing: is urology ready? A survey of authors, readers, and editorial board's knowledge, impressions and satisfaction.
World journal of urology · 2025
Effect of Complete Transurethral Resection on Oncologic Outcomes After Radiation Therapy for Muscle-Invasive Bladder Cancer
International Journal of Radiation Oncology Biology Physics · 2025

All 13 publications

Latest funding

PROPEL-AS: Prostate personalized surveillance using pathology-aligned multi-modal imaging
CIHR · 2026 · Co-investigator
$1,151,326
A paradigm shift in understanding Hunner lesion-interstitial cystitis/bladder pain syndrome: examining autoimmunity as a driver of disease and targeting B cells as a novel therapeutic opportunity
CIHR · 2023 · Co-investigator
$150,000
Role of trained immunity in the response to BCG immunotherapy of bladder cancer
CIHR · 2020 · Principal investigator
$1,086,300

All 10 grants and awards

13 publications.

Shift happens: a fairness-oriented framework for medical classification under hidden bias.

To MNN, Kim D, Harmanani M, Wilson PFR, Fooladgar F, Sojoudi S, Jamzad A, Abdalla S, Tsang T, Luong C, Chang S, Black P, Siemens R, Leveridge M, Krishnan RG, Mousavi P, Abolmaesumi P

International journal of computer assisted radiology and surgery2026

DOI: 10.1007/s11548-026-03624-0 PMID: 42032429

Open access publishing: is urology ready? A survey of authors, readers, and editorial board's knowledge, impressions and satisfaction.

Guennoun A, Bensaadi K, Simard MA, Murad L, Schwartz R, Chen K, Almousa S, Levitt M, Leveridge M, Siemens R, Larivière V, Bhojani N

World journal of urology2025

DOI: 10.1007/s00345-025-05928-3 PMID: 40924173

Effect of Complete Transurethral Resection on Oncologic Outcomes After Radiation Therapy for Muscle-Invasive Bladder Cancer

Avolio PP, Kool R, Shayegan B, Marcq G, Black PC, Breau RH, Kim M, Busca I, Abdi H, Dawidek M

International Journal of Radiation Oncology Biology Physics202515 citations

DOI: 10.1016/j.ijrobp.2024.08.036

Benefit of Whole-Pelvis Radiation for Patients With Muscle-Invasive Bladder Cancer: An Inverse Probability Treatment Weighted Analysis

Marcq G, Kool R, Dragomir A, Kulkarni GS, Breau RH, Kim M, Busca I, Abdi H, Dawidek M, Uy M

Journal of Clinical Oncology202514 citations

DOI: 10.1200/jco.23.02718

Benefit of Neoadjuvant Cisplatin-based Chemotherapy for Invasive Bladder Cancer Patients Treated with Radiation-based Therapy in a Real-world Setting: An Inverse Probability Treatment Weighted Analysis

Kool R, Dragomir A, Kulkarni GS, Marcq G, Breau RH, Kim M, Busca I, Abdi H, Dawidek M, Uy M

European Urology Oncology202430 citations

DOI: 10.1016/j.euo.2024.01.014

Bibliometric analysis of academic journal recommendations and requirements for surgical and anesthesiologic adverse events reporting.

Sholklapper TN, Ballon J, Sayegh AS, La Riva A, Perez LC, Huang S, Eppler M, Nelson G, Marchegiani G, Hinchliffe R, Gordini L, Furrer M, Brenner MJ, Dell-Kuster S, Biyani CS, Francis N, Kaafarani HMA, Siepe M, Winter D, Sosa JA, Bandello F, Siemens R, Walz J, Briganti A, Gratzke C, Abreu AL, Desai MM, Sotelo R, Agha R, Lillemoe KD, Wexner S, Collins GS, Gill I, Cacciamani GE

International journal of surgery (London, England)2023

DOI: 10.1097/js9.0000000000000323 PMID: 37132189

Development and Acceptability Testing of a Patient Decision Aid for Urinary Diversion with Radical Cystectomy.

McAlpine K, Lavallée LT, Stacey D, Moodley P, Cagiannos I, Morash C, Black PC, Kulkarni GS, Shayegan B, Kassouf W

Investigative Urology201931 citations

DOI: 10.1097/ju.0000000000000341

Prognostic pathological factors in radical cystectomy after neoadjuvant chemotherapy.

Brimo F, Downes MR, Jamaspishvili T, Berman D, Barkan GA, Athanazio D, Abro S, Visram K, Yilmaz A, Solanki S, Hahn E, Siemens R, Kassouf W, Trpkov K

Histopathology2018

DOI: 10.1111/his.13654 PMID: 29776013

A Phase II, Randomized, Multicenter Study Comparing 10 Months versus 4 Months of Degarelix Therapy in Prolonging the Off Treatment Interval in Men with Localized Prostate Cancer Receiving Intermittent Androgen Deprivation Therapy for Biochemical Recurrence following Radical Local Therapy.

Klotz L, Loblaw A, Siemens R, Ouellette P, Kapoor A, Kebabdjian M, Zhang L, Saad F, Canadian Urology Research Consortium

The Journal of urology2018

DOI: 10.1016/j.juro.2018.03.010 PMID: 29534997

Quality indicators in the management of bladder cancer: A modified Delphi study

Khare SR, Aprikian A, Black P, Blais N, Booth C, Brimo F, Chin J, Chung P, Drachenberg D, Eapen L

Urologic Oncology: Seminars and Original Investigations201725 citations

DOI: 10.1016/j.urolonc.2016.12.003

Something wrong or missing on this profile? Suggest a correction

Robert Siemens

Research

Latest papers

Latest funding

Shift happens: a fairness-oriented framework for medical classification under hidden bias.

Open access publishing: is urology ready? A survey of authors, readers, and editorial board's knowledge, impressions and satisfaction.

Effect of Complete Transurethral Resection on Oncologic Outcomes After Radiation Therapy for Muscle-Invasive Bladder Cancer

Benefit of Whole-Pelvis Radiation for Patients With Muscle-Invasive Bladder Cancer: An Inverse Probability Treatment Weighted Analysis

Benefit of Neoadjuvant Cisplatin-based Chemotherapy for Invasive Bladder Cancer Patients Treated with Radiation-based Therapy in a Real-world Setting: An Inverse Probability Treatment Weighted Analysis

Bibliometric analysis of academic journal recommendations and requirements for surgical and anesthesiologic adverse events reporting.

Development and Acceptability Testing of a Patient Decision Aid for Urinary Diversion with Radical Cystectomy.

Prognostic pathological factors in radical cystectomy after neoadjuvant chemotherapy.

A Phase II, Randomized, Multicenter Study Comparing 10 Months versus 4 Months of Degarelix Therapy in Prolonging the Off Treatment Interval in Men with Localized Prostate Cancer Receiving Intermittent Androgen Deprivation Therapy for Biochemical Recurrence following Radical Local Therapy.

Quality indicators in the management of bladder cancer: A modified Delphi study

Decision support for augmented ultrasound-guided prostate biopsy

Frequent collaborators

Wassim Kassouf

Bobby Shayegan

Alice Dragomir

Purang Abolmaesumi

Alan So

Parvin Mousavi

Peter Black

Christina Luong

Gregg Nelson

Libni Eapen

Andrew Loblaw

Nicholas Power

Purang Abolmaesumi

Neil Fleshner

Mehdi Moradi

David Berman

Girish Kulkarni

Ilias Cagiannos

Dawn Stacey

Teresa Tsang

Gregg Nelson